Authors: RATANATHARATHORN V NASH RA PRZEPIORKA D DEVINE SM KLEIN JL WEISDORF D FAY JW NADEMANEE A ANTIN JH CHRISTIANSEN NP VANDERJAGT R HERZIG RH LITZOW MR WOLFF SN LONGO WL PETERSEN FB KARANES C AVALOS B STORB R BUELL DN MAHER RM FITZSIMMONS WE WINGARD JR

Citation: V. Ratanatharathorn et al., PHASE-III STUDY COMPARING METHOTREXATE AND TACROLIMUS (PROGRAF, FK506) WITH METHOTREXATE AND CYCLOSPORINE FOR GRAFT-VERSUS-HOST DISEASE PROPHYLAXIS AFTER HLA-IDENTICAL SIBLING BONE-MARROW TRANSPLANTATION, Blood, 92(7), 1998, pp. 2303-2314

Authors: LAKE DE KUNZWEILER J BEER M BUELL DN ISLAM MZ

Citation: De. Lake et al., FLUCONAZOLE VERSUS AMPHOTERICIN-B IN THE TREATMENT OF ESOPHAGEAL CANDIDIASIS IN CANCER-PATIENTS, Chemotherapy, 42(4), 1996, pp. 308-314

Authors: RATANATHARATHORN V NASH RA DEVINE SM PRZEPIORKA D KLEIN JL WEISDORF DJ FAY JW NADEMANEE AP ANTIN JH KARANES C AVALOS BR CHRISTIANSEN NP VANDERJAGT RH HERZIG RH LITZOW MR WOLFF SN LONGO WR PETERSEN FB BUELL DN MAHER RM FITZSIMMONS WE WINGARD JR

Citation: V. Ratanatharathorn et al., PHASE-III STUDY COMPARING TACROLIMUS (PROGRAF(R), FK506) WITH CYCLOSPORINE FOR GRAFT-VERSUS-HOST DISEASE (GVHD) PROPHYLAXIS AFTER HLA-IDENTICAL SIBLING BONE-MARROW TRANSPLANTATION (BMT), Blood, 88(10), 1996, pp. 1826-1826